Why the study?
Does type 2 diabetes mellitus affect corneal endothelial cell density, corneal thickness, and intraocular pressure compared to healthy controls?
Does type 2 diabetes mellitus affect corneal endothelial cell density, corneal thickness, and intraocular pressure compared to healthy controls?
Type 2 diabetes is associated with significant changes in corneal endothelial cell density, central corneal thickness, and intraocular pressure, independent of disease duration or treatment modality.
Type 2 DM alters CCT, ECD, and IOP independently of duration or treatment; leaves open thresholds for monitoring or surgical risk.
We sought to evaluate central corneal thickness (CCT), corneal endothelial cell density (ECD) and intraocular pressure (IOP) in patients with type 2 diabetes mellitus (DM) and to associate potential differences with diabetes duration and treatment modality in a prospective, randomized study. We measured ECD, CCT and IOP of 125 patients with type 2 DM (mean age 57.1?11.5 years) and compared them with 90 age-matched controls. Measured parameters were analyzed for association with diabetes duration and glucose control modalities (insulin injection or oral medication) while controlling for age. In the diabetic group, the mean ECD (2511?252 cells/mm2), mean CCT (539.7?33.6 mm) and mean IOP (18.3?2.5 mmHg) varied significantly from those the control group [ECD: 2713?132 cells/mm2 (P,0.0001), CCT: 525.0?45.3 mm (P50.003) and IOP: 16.7?1.8 mmHg (P,0.0001)]. ECD was significantly reduced by about 32 cell/mm2 for diabetics with duration of .10 years when compared with those with duration of ,10 years (P,0.05). CCT was thicker and IOP was higher for diabetics with duration of .10 years than those with duration of ,10 years (P.0.05). None of the measured parameters was significantly associated with diabetes duration and treatment modality (P.0.05). In conclusion, subjects with type 2 DM exhibit significant changes in ECD, IOP and CCT, which, however, are not correlated with disease duration or if the patients receive on insulin injection or oral medications.
No takes yet. Share an insight, caveat, or question.
Stella et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: